Boston Scientific withdraws 2026 outlook after cyberattack
Boston Scientific withdrew its 2026 sales and profit forecasts after a cyberattack disrupted operations. The company is slowly resuming production and plans to update its outlook in October.
Xurve View
Insights:
Xurve View
BOSTON SCIENTIFIC CORP withdrew its 2026 sales and profit forecasts on Tuesday morning after a cyberattack halted global manufacturing and shipping operations.
The security breach compounds a wave of digital intrusions hitting the healthcare sector, following disruptions at rivals including ABBOTT LABORATORIES, STRYKER CORP, and MEDTRONIC PLC.
